Fluoropharma Medical Correlations
| FPMI Stock | USD 0.0001 0.00 0.00% |
The correlation of Fluoropharma Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Fluoropharma |
The ability to find closely correlated positions to Fluoropharma Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fluoropharma Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fluoropharma Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fluoropharma Medical to buy it.
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Fluoropharma Pink Sheet performing well and Fluoropharma Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Fluoropharma Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| OCEA | 5.09 | (2.15) | 0.00 | 13.07 | 0.00 | 7.46 | 51.00 | |||
| ENVB | 4.53 | (1.65) | 0.00 | (1.20) | 0.00 | 9.78 | 65.81 | |||
| HEPA | 7.16 | (1.02) | 0.00 | 0.67 | 0.00 | 9.30 | 86.86 | |||
| ELEV | 5.13 | 0.68 | 0.10 | 9.23 | 5.38 | 10.77 | 40.61 | |||
| ZURA | 4.63 | (1.31) | 0.00 | (0.77) | 0.00 | 9.21 | 25.04 | |||
| CVAC | 3.50 | 0.58 | 0.16 | 0.64 | 3.30 | 8.71 | 32.27 | |||
| KRYS | 2.20 | (0.18) | 0.00 | (0.06) | 0.00 | 3.05 | 14.97 | |||
| VIR | 4.36 | 0.39 | 0.07 | 0.45 | 4.88 | 6.00 | 71.23 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Fluoropharma Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
| All Next | Launch Module |
Fluoropharma Medical Corporate Executives
Elected by the shareholders, the Fluoropharma Medical's board of directors comprises two types of representatives: Fluoropharma Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fluoropharma. The board's role is to monitor Fluoropharma Medical's management team and ensure that shareholders' interests are well served. Fluoropharma Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fluoropharma Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tamara Rhein | CFO and Principal Accounting Officer | Profile |